Clinical Trial Update: An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

View source ↗

Summary

This completed observational pilot trial evaluated the feasibility of conducting genome-wide association studies using subject-provided information in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Glioblastoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Breast Cancer, Colorectal Cancer | Status: COMPLETED